SQ-33600

• Description:

  SQ-33600 is an HMG-CoA reductase inhibitor. SQ-33600 has cholesterol-lowering activity. SQ-33600 possesses cell-type selectivity, with much higher inhibitory activity on rat hepatocytes (IC50: 93 nM) than on human skin fibroblasts (IC50: 14200 nM) . SQ-33600 can be used in the research of diseases such as hypercholesterolemia[1][2].

• UNSPSC:

  12352005

• Target:

  HMG-CoA Reductase (HMGCR)

• Related Pathways:

  Metabolic Enzyme/Protease

• Field of Research:

  Endocrinology; Metabolic Disease

• Smiles:

  O=C(C[C@@H](CP(C#CC(N1C2=CC=C(C=C2)F)=C(C3=C1C=CC=C3)C(C)C)(O[Na])=O)O)O[Na]

• Molecular Formula:

  C23H21FNNa2O5P

• Molecular Weight:

  487.37

• References & Citations:

  [1]Wang-Iverson D, et al. Determination of SQ 33,600, a phosphinic acid containing HMG CoA reductase inhibitor, in human serum by high-performance liquid chromatography combined with ionspray mass spectrometry. Biol Mass Spectrom. 1992 Apr;21 (4) :189-94.|[2]Jagoda E, et al. Radioimmunoassay for hydroxyphosphinyl-3-hydroxybutanoic acid (SQ 33,600), a hypocholesterolemia agent. Ther Drug Monit. 1993 Jun;15 (3) :213-9.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [133983-25-2]